vs

Side-by-side financial comparison of Cheer Holding, Inc. (CHR) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $71.0M, roughly 1.1× Cheer Holding, Inc.). Cheer Holding, Inc. runs the higher net margin — 10.9% vs 7.4%, a 3.5% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -0.1%).

Cheer Holding, Inc. is a diversified holding company primarily operating in the Chinese market, with core business segments covering early childhood education services, mobile lifestyle platforms, digital content offerings, and integrated consumer solutions for households and enterprise partners across multiple demand scenarios.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

CHR vs VMD — Head-to-Head

Bigger by revenue
VMD
VMD
1.1× larger
VMD
$76.2M
$71.0M
CHR
Growing faster (revenue YoY)
VMD
VMD
+25.6% gap
VMD
25.5%
-0.1%
CHR
Higher net margin
CHR
CHR
3.5% more per $
CHR
10.9%
7.4%
VMD

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
CHR
CHR
VMD
VMD
Revenue
$71.0M
$76.2M
Net Profit
$7.8M
$5.6M
Gross Margin
70.7%
57.9%
Operating Margin
11.7%
11.0%
Net Margin
10.9%
7.4%
Revenue YoY
-0.1%
25.5%
Net Profit YoY
-37.5%
30.7%
EPS (diluted)
$0.67
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHR
CHR
VMD
VMD
Q4 25
$76.2M
Q3 25
$71.9M
Q2 25
$71.0M
$63.1M
Q1 25
$59.1M
Q4 24
$60.7M
Q3 24
$58.0M
Q2 24
$71.1M
$55.0M
Q1 24
$50.6M
Net Profit
CHR
CHR
VMD
VMD
Q4 25
$5.6M
Q3 25
$3.5M
Q2 25
$7.8M
$3.2M
Q1 25
$2.6M
Q4 24
$4.3M
Q3 24
$3.9M
Q2 24
$12.4M
$1.5M
Q1 24
$1.6M
Gross Margin
CHR
CHR
VMD
VMD
Q4 25
57.9%
Q3 25
57.5%
Q2 25
70.7%
58.3%
Q1 25
56.3%
Q4 24
59.5%
Q3 24
59.3%
Q2 24
73.4%
59.8%
Q1 24
58.9%
Operating Margin
CHR
CHR
VMD
VMD
Q4 25
11.0%
Q3 25
7.8%
Q2 25
11.7%
8.1%
Q1 25
6.5%
Q4 24
10.6%
Q3 24
9.7%
Q2 24
16.4%
6.6%
Q1 24
4.4%
Net Margin
CHR
CHR
VMD
VMD
Q4 25
7.4%
Q3 25
4.9%
Q2 25
10.9%
5.0%
Q1 25
4.4%
Q4 24
7.1%
Q3 24
6.7%
Q2 24
17.5%
2.7%
Q1 24
3.2%
EPS (diluted)
CHR
CHR
VMD
VMD
Q4 25
$0.14
Q3 25
$0.09
Q2 25
$0.67
$0.08
Q1 25
$0.06
Q4 24
$0.10
Q3 24
$0.10
Q2 24
$1.23
$0.04
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHR
CHR
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$322.1M
$141.5M
Total Assets
$362.7M
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHR
CHR
VMD
VMD
Q4 25
$13.5M
Q3 25
$11.1M
Q2 25
$20.0M
Q1 25
$10.2M
Q4 24
$17.5M
Q3 24
$11.3M
Q2 24
$186.1M
$8.8M
Q1 24
$7.3M
Stockholders' Equity
CHR
CHR
VMD
VMD
Q4 25
$141.5M
Q3 25
$133.6M
Q2 25
$322.1M
$139.7M
Q1 25
$134.8M
Q4 24
$131.4M
Q3 24
$125.0M
Q2 24
$286.1M
$119.4M
Q1 24
$116.3M
Total Assets
CHR
CHR
VMD
VMD
Q4 25
$199.2M
Q3 25
$202.4M
Q2 25
$362.7M
$184.6M
Q1 25
$178.1M
Q4 24
$177.1M
Q3 24
$169.5M
Q2 24
$333.2M
$163.9M
Q1 24
$154.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHR
CHR
VMD
VMD
Operating Cash FlowLast quarter
$3.9M
$18.4M
Free Cash FlowOCF − Capex
$9.7M
FCF MarginFCF / Revenue
12.7%
Capex IntensityCapex / Revenue
11.5%
Cash ConversionOCF / Net Profit
0.51×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHR
CHR
VMD
VMD
Q4 25
$18.4M
Q3 25
$18.4M
Q2 25
$3.9M
$12.3M
Q1 25
$2.9M
Q4 24
$15.0M
Q3 24
$12.7M
Q2 24
$-6.7M
$10.2M
Q1 24
$1.2M
Free Cash Flow
CHR
CHR
VMD
VMD
Q4 25
$9.7M
Q3 25
$10.7M
Q2 25
$4.1M
Q1 25
$-12.6M
Q4 24
$3.2M
Q3 24
$1.7M
Q2 24
$1.2M
Q1 24
$-4.8M
FCF Margin
CHR
CHR
VMD
VMD
Q4 25
12.7%
Q3 25
14.9%
Q2 25
6.5%
Q1 25
-21.4%
Q4 24
5.2%
Q3 24
3.0%
Q2 24
2.3%
Q1 24
-9.5%
Capex Intensity
CHR
CHR
VMD
VMD
Q4 25
11.5%
Q3 25
10.6%
Q2 25
12.9%
Q1 25
26.2%
Q4 24
19.5%
Q3 24
19.0%
Q2 24
16.3%
Q1 24
11.9%
Cash Conversion
CHR
CHR
VMD
VMD
Q4 25
3.27×
Q3 25
5.23×
Q2 25
0.51×
3.88×
Q1 25
1.09×
Q4 24
3.47×
Q3 24
3.29×
Q2 24
-0.54×
6.94×
Q1 24
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons